Molecular magnetic resonance probe targeting VEGF165: Preparation and in vitro and in vivo evaluation

Contrast Media and Molecular Imaging

Volumn 9, Issue 5, 2014, Pages 349-354

  You, Xiao Guang ^a   Tu, Rong ^a   Peng, Ming Li ^b   Bai, Yu Jie ^a   Tan, Mingqian ^c   Li, Han Jian ^a   Guan, Jing ^d   Wen, Li Jun ^a  

^a HAINAN MEDICAL UNIVERSITY   (China)

^b NORTHWEST UNIVERSITY   (China)

^c DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^d Department of Radiology Zhunyi Medical College Hopital   (China)

Author keywords

(USPIO); Aptamer; Liver cancer; MRI; Targeted molecular probe; VEGF165

Indexed keywords

APTAMER; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; VASCULOTROPIN 165; CONTRAST MEDIUM; DEXTRAN; FERUMOXTRAN-10; MAGNETITE NANOPARTICLE; MOLECULAR PROBE; PEPTIDE APTAMER; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CROSS LINKING; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL ELECTROPHORESIS; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER; MALE; MOLECULAR PROBE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; SIGNAL NOISE RATIO; TRANSMISSION ELECTRON MICROSCOPY; TUMOR XENOGRAFT; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; CHEMISTRY; DIAGNOSTIC USE; HUMAN; ISOLATION AND PURIFICATION; TUMOR CELL LINE;

ANIMALS; APTAMERS, NUCLEOTIDE; APTAMERS, PEPTIDE; CELL LINE, TUMOR; CONTRAST MEDIA; DEXTRANS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICE; MOLECULAR PROBES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84908014746     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.1584     Document Type: Article

References (23)

1. Hak S, Reitan NK, Haraldseth O, et al. Intravital microscopy in window chambers: a unique tool to study tumor angiogenesis and delivery of nanoparticles. Angiogenesis 2010; 13(2): 113-130; doi: 10.1007/s10456-010-9176-y
2. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 2005; 23(5): 1011-1027; doi: 10.1200/JCO.2005.06.081
3. Sauter ER, Nesbit M, Watson JC, et al. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin Cancer Res 1999; 5(4): 775-782.
4. Jayson GC, Zweit J, Jackson A, et al. Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implications for trial design of antiangiogenic antibodies. J Natl Cancer Inst 2002; 94(19): 1484-1493; doi: 10.1093/jnci/94.19.1484
5. Nagengast WB, de Korte MA, Oude Munnink TH, et al. 89Zr-bevacizumab PET of early antiangiogenic tumor response to treatment with HSP90 inhibitor NVP-AUY922. J Nucl Med 2010; 51(5): 761-767; doi: 10.2967/jnumed.109.071043
6. Anderson CR, Rychak JJ, Backer M, et al. scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis. Invest Radiol 2010; 45(10): 579-585; doi: 10.1097/RLI.0b013e3181efd581
7. Liu Y, Chen Z, Liu C, Yu D, et al. Gadolinium-loaded polymeric nanoparticles modified with Anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer. Biomaterials 2011; 32(22): 5167-5176; doi: 10.1016/j.biomaterials.2011.03.077
8. Cho EJ, Lee JW, Ellington AD.Applications of aptamers as sensors. Annu Rev Anal Chem 2009; 2: 241-264; doi: 10.1146/annurev.anchem.1.031207.112851
9. Soontornworajit B, Wang Y. Nucleic acid aptamers for clinical diagnosis: cell detection and molecular imaging. Anal Bioanal Chem 2011; 399(4): 1591-1599; doi: 10.1007/s00216-010-4559-x
10. Cerchia L, de Franciscis V. Targeting cancer cells with nucleic acid aptamers. Trends Biotechnol 2010; 28(10): 517-525; doi: 10.1016/j.tibtech.2010.07.005
11. Lee JH, Canny MD, Erkenez AD, et al. A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165. Proc Natl Acad Sci U S A 2005; 102(52): 18902-18907; doi: 10.1073/pnas.0509069102
12. Liu Z, Wang F. Dual-targeted molecular probes for cancer imaging. Curr Pharm Biotechnol 2010; 11(6): 610-619. PII:BSP/CPB/E-Pub/0084-11-6
13. Chen K, Chen X. Design and development of molecular imaging probes. Curr Top Med Chem 2010; 10(12): 1227-1236; PII: BSP/ CTMC /E-Pub/-0071-10-11
14. Lee S, Xie J, Chen X. Activatable molecular probes for cancer imaging. Curr Top Med Chem 2010; 10(11): 1135-1144; PII:BSP/ CTMC /E-Pub/-0065-10-11
15. John R, Boppart SA. Magnetomotive molecular nanoprobes. Curr Med Chem 2011; 18(14): 2103-2114; PII:BSP/CMC/E-Pub/2011/ 148
16. Bogdanov A Jr, Mazzanti ML. Molecular magnetic resonance contrast agents for the detection of cancer: past and present. Semin Oncol 2011; 38(1): 42-54; doi: 10.1016/j.biomaterials.2010.10.034
17. Ko HY, Choi KJ, Lee CH, et al. A multimodal nanoparticle-based cancer imaging probe simultaneously targeting nucleolin, integrin αvβ3 and tenascin-C proteins. Biomaterials 2011; 32(4): 1130-1138; doi: 10.1016/j.biomaterials.2010.10.034
18. Li S, He H, Cui W, et al. Detection of Aβ plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP/PS1 transgenic mice. Anat Rec 2010; 293(12): 2136-2143; doi: 10.1002/ar.21209
19. Wang AZ, Bagalkot V, Vasilliou CC, et al. Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy. Chem Med Chem 2008; 3(9): 1311-1315; doi: 10.1002/cmdc.200800091
20. Liu Z, Zhao Y, Li J, et al. The venom of the spider Macrothele raveni induces apoptosis in the myelogenous leukemia K562 cell line. Leuk Res 2012; 36(8): 1063-1066.
21. Hsieh WJ, Liang CJ, Chieh JJ et al. In vivo tumor targeting and imaging with anti-vascular endothelial growth factor antibody-conjugated dextran-coated iron oxide nanoparticles. Int J Nanomed 2012; 7: 2833-2842; doi: 10.2147/IJN.S32154
22. Leung K. Ovarian cancer antigen 183B2 monoclonal antibody conjugated to ultrasmall superparamagnetic iron oxide nanoparticles. Molecular Imaging and Contrast Agent Database. National Center for Biotechnology Information: Bethesda MD, 2004-2011 (updated 14 April 2011]. Bookaccession: NBK53963.
23. Spanholtz TA, Theodorou P, Holzbach T, et al. Vascular endothelial growth factor (VEGF165) plus basic fibroblast growth factor (bFGF) producing cells induce a mature and stable vascular network - a future therapy for chemically challenged tissue. J Surg Res 2011; 171(1): 329-38; doi: 10.1016/j.jss.2010.03.033